Answer
Apr 01, 2026 - 08:52 AM
Humira carries a boxed warning for increased risk of serious infections (including tuberculosis, sepsis, invasive fungal infections, and opportunistic infections) and increased risk of malignancies (cancer), particularly lymphoma, leukemia, and skin cancer. A boxed warning is the FDA’s most serious warning, highlighting risks that are critical for patients and providers to consider when starting therapy.
